Chang David J. 4

What Happened
David J. Chang, Chief Medical Officer of Cabaletta Bio (CABA), acquired 8,800 shares on January 21, 2026. The Form 4 reports a purchase (transaction code P) at $2.26 per share, for a total cost of $19,888. This was an acquisition (purchase), which investors often view as a more informative signal than routine sales.

Key Details

• Transaction date: 2026-01-21
• Price per share: $2.26; Total value: $19,888
• Transaction type: Purchase (code P) — filing describes as open market or private purchase
• Shares owned after transaction: Not specified in the provided filing details
• Filing timeliness: Reported on 2026-01-21 (same day as the transaction date provided), so appears timely
• No footnotes in the provided data indicating a 10b5-1 plan, tax withholding, or cashless exercise

Context
Open-market purchases by company executives can signal confidence but are not definitive evidence of future performance. This was a straightforward buy (not an option exercise or gift). The size ($19.9k) is modest relative to many insider trades; treat it as a data point rather than a decisive indicator.